Ernexa Therapeutics, Inc. (ERNA)
0.197
+0.01
(+4.18%)
USD |
NASDAQ |
Apr 16, 16:00
0.1907
-0.01
(-3.20%)
After-Hours: 05:51
Ernexa Therapeutics Research and Development Expense (Quarterly) : 0.676M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Ocular Therapeutix, Inc. | 50.80M |
| Quince Therapeutics, Inc. | 12.60M |
| Recursion Pharmaceuticals, Inc. | 83.34M |
| Tango Therapeutics, Inc. | 31.62M |
| Aprea Therapeutics, Inc. | 1.009M |